Advertisement
BDX or RVTY or STE
Which Stock Would AI Choose? Becton, Dickinson and Company (BDX) vs. Revvity, Inc. (RVTY) vs. STERIS plc (STE) Stock Comparison
Key Takeaways
- BDX boasts the largest market capitalization at approximately $42.5 billion, offering greater stability compared to RVTY ($9.7 billion) and STE (around $21 billion).
- All three stocks have declined over the past year—BDX by about 12%, RVTY by 8-12%, and STE by 4%—reflecting broader healthcare sector pressures.
- Recent market activity shows BDX gaining 3.4% over the last four weeks, outperforming peers amid anticipated earnings challenges.
- Analyst price targets suggest upside potential: BDX to $191 (28% from $149), RVTY to $110 (27% from $87), with STE maintaining stable outlooks.
- Year-to-date in 2026, all lag the S&P 500, with RVTY down most sharply at around 15%.
Introduction
Becton, Dickinson and Company (BDX), Revvity, Inc. (RVTY), and STERIS plc (STE) are key players in the medtech and life sciences sectors, providing essential devices, diagnostics, and infection prevention solutions. This stock comparison analyzes their recent performance, business models, and market positioning amid healthcare sector headwinds like earnings pressures and shifting sentiment. Traders seeking defensive healthcare exposure or investors evaluating relative strength in medical technology will find insights into momentum, valuation sensitivity, and growth drivers.
BDX Overview and Recent Performance
Becton, Dickinson and Company (BDX) is a global leader in medical technology, focusing on medical devices, diagnostics, and biosciences products. Its shares trade around $149, within a 52-week range of $128 to $187. In recent market activity, BDX has shown resilience, gaining over 3% in the past four weeks despite year-to-date declines and anticipated Q2 2026 earnings drops of 17% year-over-year. Sentiment reflects concerns over revenue softness but is bolstered by a consensus "Buy" rating and analyst targets implying significant upside, driven by its diversified portfolio and stable demand in diagnostics.
RVTY Overview and Recent Performance
Revvity, Inc. (RVTY), formerly PerkinElmer, specializes in life sciences solutions, health sciences, and diagnostics services. Trading near $87, its 52-week range spans $81 to $118. Recent performance has been challenged, with shares down sharply year-to-date by about 15% and over 7% in the past year, amid weak revenue growth and margin pressures. Shareholder actions like board re-elections signal continuity, but analyst sentiment is mixed due to declining trends. Upside potential exists via targets around $110, supported by achievable guidance in life sciences tools.
STE Overview and Recent Performance
STERIS plc (STE) provides infection prevention and healthcare products, including sterilization equipment and surgical support services. Shares hover around $213, in a 52-week band of $210 to $269. Recent weeks have seen a pullback below key moving averages (50-day at $239, 200-day at $248), contributing to a 4% annual decline and modest YTD losses. Performance reflects scrutiny on return on invested capital and Q4 2026 earnings outlook, though steady demand in healthcare facilities underpins stability. Analysts note share buybacks as a supportive factor.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the top 25 performers from its library of 351 AI trading bots, which trade thousands of tickers across stocks, ETFs, and crypto using diverse strategies like technical analysis, fundamentals, and machine learning on timeframes from 5 minutes to 49 days. These curated bots excel in current volatile conditions, posting annualized returns from +23% to +162%, win rates of 51% to 88%, profit factors up to 11.7, and profit-to-drawdown ratios as high as 17. Highlighted performers target sectors like semiconductors (e.g., +96% on LRCX/TER), industrials (+94%), and small caps (+93%), with drawdowns managed from $1,500 to $49,000. Explore these for automated trading insights tailored to market dynamics.
Head-to-Head Comparison
BDX, RVTY, and STE operate in complementary medtech niches: BDX emphasizes broad devices and diagnostics, RVTY focuses on life sciences tools and services, while STE leads in sterilization and procedural support. Growth drivers include recurring healthcare demand, but recent momentum favors BDX's short-term gains over peers' pullbacks. Risk factors involve earnings volatility (e.g., BDX and RVTY declines) and sector sensitivity to margins. Valuation-wise, BDX's P/E (price-to-earnings ratio) of 24x aligns closely with industry averages, versus peers' pressures. Market sentiment leans positive on analyst upgrades, with BDX positioned for relative outperformance due to scale.
Tickeron AI Verdict
Tickeron’s AI models currently favor BDX among the trio, citing its superior recent trend consistency (3%+ four-week gain), larger scale for stability, and higher analyst-implied upside amid healthcare volatility. While RVTY and STE offer targeted exposures, BDX's diversified catalysts position it probabilistically stronger in the near term.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 1 green FA rating(s), and STE’s FA Score reflects 1 green FA rating(s).
- BDX’s FA Score: 1 green, 4 red.
- RVTY’s FA Score: 1 green, 4 red.
- STE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 6 TA indicator(s) are bullish while RVTY’s TA Score has 6 bullish TA indicator(s), and STE’s TA Score reflects 6 bullish TA indicator(s).
- BDX’s TA Score: 6 bullish, 2 bearish.
- RVTY’s TA Score: 6 bullish, 4 bearish.
- STE’s TA Score: 6 bullish, 2 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а -0.38% price change this week, while RVTY (@Medical Specialties) price change was -3.45% , and STE (@Medical/Nursing Services) price fluctuated +1.69% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.56%. For the same industry, the average monthly price growth was -3.93%, and the average quarterly price growth was +47.01%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +9.54%. For the same industry, the average monthly price growth was +2.29%, and the average quarterly price growth was -4.23%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.16%. For the same industry, the average monthly price growth was -6.78%, and the average quarterly price growth was -1.95%.
Reported Earning Dates
BDX is expected to report earnings on Jul 30, 2026.
RVTY is expected to report earnings on Aug 03, 2026.
STE is expected to report earnings on Aug 10, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-0.56% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (+9.54% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.16% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BDX | RVTY | STE | |
| Capitalization | 40.5B | 10.7B | 21B |
| EBITDA | 4.97B | 766M | 1.49B |
| Gain YTD | -3.098 | -0.772 | -15.208 |
| P/E Ratio | 25.65 | 46.09 | 27.04 |
| Revenue | 22.2B | 2.86B | 5.83B |
| Total Cash | 816M | N/A | 424M |
| Total Debt | 17.3B | 3.4B | 2.05B |
BDX | RVTY | STE | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 77 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 50 Fair valued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 89 | |
SMR RATING 1..100 | 86 | 88 | 68 | |
PRICE GROWTH RATING 1..100 | 62 | 42 | 63 | |
P/E GROWTH RATING 1..100 | 76 | 30 | 83 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDX's Valuation (15) in the Medical Specialties industry is in the same range as STE (18) and is somewhat better than the same rating for RVTY (50). This means that BDX's stock grew similarly to STE’s and somewhat faster than RVTY’s over the last 12 months.
STE's Profit vs Risk Rating (89) in the Medical Specialties industry is in the same range as BDX (100) and is in the same range as RVTY (100). This means that STE's stock grew similarly to BDX’s and similarly to RVTY’s over the last 12 months.
STE's SMR Rating (68) in the Medical Specialties industry is in the same range as BDX (86) and is in the same range as RVTY (88). This means that STE's stock grew similarly to BDX’s and similarly to RVTY’s over the last 12 months.
RVTY's Price Growth Rating (42) in the Medical Specialties industry is in the same range as BDX (62) and is in the same range as STE (63). This means that RVTY's stock grew similarly to BDX’s and similarly to STE’s over the last 12 months.
RVTY's P/E Growth Rating (30) in the Medical Specialties industry is somewhat better than the same rating for BDX (76) and is somewhat better than the same rating for STE (83). This means that RVTY's stock grew somewhat faster than BDX’s and somewhat faster than STE’s over the last 12 months.
| BDX | RVTY | STE | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 48% | 1 day ago 59% | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 71% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 49% | 1 day ago 67% | 1 day ago 52% |
| MACD ODDS (%) | 1 day ago 46% | 1 day ago 67% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 44% | 1 day ago 67% | 1 day ago 55% |
| TrendMonth ODDS (%) | 1 day ago 43% | 1 day ago 61% | 1 day ago 52% |
| Advances ODDS (%) | 14 days ago 43% | 1 day ago 66% | 1 day ago 50% |
| Declines ODDS (%) | 3 days ago 42% | 22 days ago 66% | 10 days ago 53% |
| BollingerBands ODDS (%) | 1 day ago 48% | 1 day ago 73% | 1 day ago 62% |
| Aroon ODDS (%) | 1 day ago 43% | 1 day ago 59% | 1 day ago 54% |
Advertisement
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with TMO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | +3.23% | ||
| TMO - BDX | 50% Loosely correlated | +1.31% | ||
| COO - BDX | 48% Loosely correlated | +0.84% | ||
| CNMD - BDX | 48% Loosely correlated | -1.17% | ||
| BAX - BDX | 47% Loosely correlated | +3.04% | ||
| RVTY - BDX | 45% Loosely correlated | +0.41% | ||
More | ||||